Bright Minds Biosciences (DRUG) stays a Strong Buy after Phase 2 BMB-101 seizure-reduction data; see 2026 catalysts, ...
SAN DIEGO, CA / ACCESS Newswire / January 7, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or ...
As South Sudan teeters on the brink of a second civil war, young people are using music to promote peace and unity.
Techceuticals has announced its 2026 training schedule for solid dosage manufacturing, featuring a full lineup of two-day, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback